Symons Capital Management Inc. trimmed its position in shares of Clorox Co (NYSE:CLX) by 10.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 53,106 shares of the company’s stock after selling 6,098 shares during the period. Clorox comprises 3.7% of Symons Capital Management Inc.’s holdings, making the stock its 6th biggest holding. Symons Capital Management Inc.’s holdings in Clorox were worth $8,065,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in Clorox by 0.8% in the 2nd quarter. Vanguard Group Inc. now owns 15,541,246 shares of the company’s stock worth $2,379,520,000 after acquiring an additional 126,624 shares in the last quarter. Parnassus Investments CA grew its stake in Clorox by 0.4% in the 3rd quarter. Parnassus Investments CA now owns 4,651,499 shares of the company’s stock worth $706,423,000 after acquiring an additional 17,409 shares in the last quarter. Northern Trust Corp grew its stake in Clorox by 0.6% in the 2nd quarter. Northern Trust Corp now owns 2,369,859 shares of the company’s stock worth $362,850,000 after acquiring an additional 14,792 shares in the last quarter. Morgan Stanley lifted its position in shares of Clorox by 8.1% in the 2nd quarter. Morgan Stanley now owns 2,192,928 shares of the company’s stock worth $335,759,000 after purchasing an additional 165,160 shares during the period. Finally, Janus Henderson Group PLC lifted its position in shares of Clorox by 1.9% in the 2nd quarter. Janus Henderson Group PLC now owns 1,804,217 shares of the company’s stock worth $276,243,000 after purchasing an additional 33,032 shares during the period. Institutional investors own 78.42% of the company’s stock.
NYSE:CLX traded up $0.98 during midday trading on Friday, reaching $148.00. 639,305 shares of the stock traded hands, compared to its average volume of 896,025. Clorox Co has a 12-month low of $143.58 and a 12-month high of $167.70. The business has a 50-day moving average of $149.93 and a two-hundred day moving average of $154.33. The company has a debt-to-equity ratio of 4.69, a quick ratio of 0.52 and a current ratio of 0.87. The stock has a market capitalization of $18.55 billion, a PE ratio of 23.42, a price-to-earnings-growth ratio of 4.73 and a beta of 0.38.
Clorox (NYSE:CLX) last posted its earnings results on Thursday, October 31st. The company reported $1.59 EPS for the quarter, beating the Zacks’ consensus estimate of $1.54 by $0.05. Clorox had a net margin of 13.20% and a return on equity of 123.56%. The company had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.51 billion. During the same quarter in the prior year, the company posted $1.62 earnings per share. Clorox’s revenue for the quarter was down 3.6% compared to the same quarter last year. Research analysts anticipate that Clorox Co will post 6.16 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Wednesday, October 30th will be given a dividend of $1.06 per share. The ex-dividend date is Tuesday, October 29th. This represents a $4.24 dividend on an annualized basis and a yield of 2.86%. Clorox’s payout ratio is 67.09%.
In other Clorox news, SVP Andrew J. Mowery sold 5,648 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $146.29, for a total transaction of $826,245.92. Following the transaction, the senior vice president now owns 15,920 shares in the company, valued at approximately $2,328,936.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Michael R. Costello sold 6,997 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the transaction, the senior vice president now owns 29,016 shares in the company, valued at approximately $4,716,840.96. The disclosure for this sale can be found here. Insiders have sold 15,870 shares of company stock valued at $2,484,000 in the last three months. 1.14% of the stock is currently owned by corporate insiders.
CLX has been the subject of several research reports. Royal Bank of Canada upped their price target on shares of Clorox to $161.00 and gave the stock a “sector perform” rating in a research report on Friday, August 2nd. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price target for the company in a research report on Monday, July 29th. Wells Fargo & Co reaffirmed a “hold” rating and issued a $150.00 price target on shares of Clorox in a research report on Wednesday, October 2nd. Cfra cut shares of Clorox from a “hold” rating to a “sell” rating in a research report on Friday, November 1st. Finally, Deutsche Bank decreased their target price on shares of Clorox from $151.00 to $145.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Five equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $152.00.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.